CLINICAL_TRIALS
trial_result
· 2024-06-13
Clinical Trial Update: Dapagliflozin In Alzheimer's Disease [Phase 1, Phase 2]
Summary
This document reports the completion and results posting of Phase 1/2 trials evaluating dapagliflozin for Alzheimer's disease.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Jeff Burns, MD | Conditions: Alzheimer Disease | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-06-13